SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. 1) (1)
COMMONWEALTH BIOTECHNOLOGIES, INC.
(Name of Issuer)
COMMON STOCK, NO PAR VALUE
(Title of Class of Securities)
202739108
(CUSIP Number)
BRADLEY A. BROWN, MILLS VALUE ADVISER, INC.,
707 EAST MAIN STREET, RICHMOND, VIRGINIA 23219 (804) 344-3532
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
September 25, 2000
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box
[ ].
Note: Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Rule 13d-1(a) for
other parties to whom copies are to be sent.
(Continued on following pages)
(Page 1 of 6 Pages)
(1)The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934, as amended (the "Act"), or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
<PAGE>
CUSIP No. 202739108 SCHEDULE 13D Page 2 of 6 Pages
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Juniper Trading Services, Inc.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
Not Applicable
3 SEC USE ONLY
4 SOURCE OF FUNDS*
OO
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(d) or 2(e) [ ]
Not Applicable
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Bermuda
NUMBER OF 7 SOLE VOTING POWER
SHARES 719,500
8 SHARED VOTING POWER
BENEFICIALLY -0-
OWNED BY EACH 9 SOLE DISPOSITIVE POWER
REPORTING 229,035
10 SHARED DISPOSITIVE POWER
PERSON WITH -0-
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
719,500
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
Not Applicable
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
35.1%
14 TYPE OF REPORTING PERSON*
CO
*See Instructions Before Filling Out!
<PAGE>
Amendment No. 1
To
SCHEDULE 13D
FOR
Juniper Trading Services, Inc.
Item 1. Security and Issuer
This Amendment No. 1 amends and supplements the
Schedule 13D dated May 24, 2000 with regard to the common
stock, no par value per share (the "Common Stock"), of
Commonwealth Biotechnologies, Inc., 601 Biotech Drive,
Richmond, VA 23235 (the "Issuer").
Item 2. Identity and Background
(A) Juniper Trading Services, Inc.
(B) Compass Point Building
9 Bermudiana Road
Hamilton, HM 11 Bermuda
(C) N/A.
(D) During the past five years, Juniper Trading Services,
Inc. has not been convicted in a criminal proceeding,
excluding traffic violations or similar misdemeanors.
(E) During the past five years, Juniper Trading Services,
Inc. has not been a party to a civil proceeding of a
judicial or administrative body of competent
jurisdiction and has not been subject to a judgment,
decree or final order enjoining future violations of,
or prohibiting or mandating activities subject to,
federal or state securities laws or finding any
violation with respect to such laws.
(F) Juniper Trading Services, Inc. is incorporated under
the laws of Bermuda.
Item 3. Source and Amount of Funds and Other Consideration
The total amount of the funds used in making the purchases was
$2,600,000. The source of the funds used in making the
purchases was working capital and other sources.
Item 4. Purpose of Transaction
Juniper Trading Services, Inc. has purchased shares of Common
Stock for investment purposes.
There are no plans or proposals which Juniper Trading
Services, Inc. may have that relate to or would result in:
(A) The acquisition by any person of additional securities
of the Issuer, or the disposition of securities of the
Issuer, except as otherwise disclosed herein;
(B) An extraordinary corporate transaction, such as a
merger, reorganization or liquidation, involving the
Issuer or any of its subsidiaries;
(C) A sale or transfer of a material amount of assets of
the Issuer or of any of its subsidiaries;
Page 3 of 6
<PAGE>
(D) Any change in the present board of directors or
management of the Issuer, including any plans or proposals
to change the number or term of directors or to fill any
existing vacancies on the board;
(E) Any material change in the present capitalization or
dividend policy of the Issuer;
(F) Any other material change in the Issuer's business or
corporate structure;
(G) Changes in the Issuer's charter, bylaws or instruments
corresponding thereto or other actions which may impede
the acquisition of control of the Issuer by any person;
(H) Causing a class of securities of the Issuer to be
delisted from a national securities exchange or to cease
to be authorized to be quoted in an inter-dealer quotation
system of a registered national securities association;
(I) A class of equity securities of the Issuer becoming
eligible for termination of registration pursuant to
Section 12(g)(4) of the Securities Exchange Act of 1934,
as amended; or
(J) Any action similar to any of those enumerated above.
Item 5. Interest in Securities of the Issuer
(A) The aggregate number and percentage of Common Stock
beneficially owned by Juniper Trading Services, Inc. are
719,500 shares and 35.1%, respectively.
(B) Juniper Trading Services, Inc. has the sole power to
vote or to direct the vote of the shares identified
pursuant to Item 5(a). Juniper Trading Services, Inc. has
sole power to dispose or to direct the disposition of
229,035 shares identified pursuant to Item 5(a).
(C) Purchases the securities identified pursuant to Item
5(a) within the last 60 days:
Beneficial Date of Number of Price Per How Acquired
Owner Transaction Shares Share / Sold
JTS 9/25/00 348,000 $7.47 Private Placement
(D) James Thomas Martin has the right to receive dividends
from and the proceeds of sale from the Common Stock to the
same extent as Juniper Trading Services, Inc. inasmuch as
Mr. Martin has total beneficial ownership of Juniper
Trading Services, Inc.
(E) Not applicable.
Page 4 of 6
<PAGE>
Item 6. Contracts, Arrangements, Understandings or Relationships with
Respect to Securities of the Issuer
None.
Item 7. Material to be Filed as Exhibits
None.
Page 5 of 6
<PAGE>
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement on Schedule 13D is
true, complete and correct.
Date: October 10, 2000
/s/ Jamie Gutteridge
-------------------------------
Jamie Gutteridge, for and on behalf of
Compass Services Limited, a director of
Juniper Trading Services, Inc.
Attention: Intentional misstatements or omissions of fact constitute Federal
criminal violations (see 18 U.S.C. 1001).
Page 6 of 6
